Bristol Myers Squibb (BMY) Curent Deferred Tax Liability (2009 - 2012)

Bristol Myers Squibb has disclosed Curent Deferred Tax Liability across 4 years of filings, most recently posting -$10.0 million for Q4 2012.

• In Q4 2012, Curent Deferred Tax Liability fell 66.67% year-over-year to -$10.0 million; the TTM figure through Dec 2012 stood at -$10.0 million (down 66.67% YoY), while the FY2012 annual figure was -$10.0 million, down 66.67% from the prior year.
• Curent Deferred Tax Liability declined to -$10.0 million in Q4 2012, from -$6.0 million in the prior quarter.
• Over the last five years, Curent Deferred Tax Liability for BMY reached as high as $8.0 million in Q4 2009 and fell as low as -$10.0 million in Q4 2012.
• The 4-year median for Curent Deferred Tax Liability is -$5.5 million (2010), against an average of -$3.2 million.
• Annual changes were most pronounced in 2010 — Curent Deferred Tax Liability slumped 162.5% — and 2011, when it dropped 20.0%.
• A 4-year view of Curent Deferred Tax Liability shows it stood at $8.0 million in 2009, then tumbled by 162.5% to -$5.0 million in 2010, then decreased by 20.0% to -$6.0 million in 2011, then tumbled by 66.67% to -$10.0 million in 2012.
• According to Business Quant data, Curent Deferred Tax Liability over the past three periods registered -$10.0 million, -$6.0 million, and -$5.0 million for Q4 2012, Q4 2011, and Q4 2010 respectively.